B+
Bull case
30%
Probability
Target price
$105.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
LMAT
LeMaitre VascularBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Strong Q2 organic growth, Artegraft momentum, higher pricing, mix, operating efficiencies, and substantial cash support a recovery toward the reported $116.25 median target if the guidance reset proves conservative.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +9.4.
What can break
Catheter sales fell 11% in Q2 due to recall-driven overstocking in the year-ago period.
Momentum
6
Value
56
Sentiment
78
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $88.00 · Bull $105.00 · Bear $65.00Analysis 2026-08-06; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-06 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $107.00
Why
Momentum6 · Δ7d -0.5
Value56 · Δ7d -0.1
Sentiment78 · Δ7d +9.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +9.4.
Contradictions & invalidation
- • Catheter sales fell 11% in Q2 due to recall-driven overstocking in the year-ago period.
- • Full-year 2026 sales, operating-income, and EPS guidance declined from the prior May outlook.
- • The full-year guide reduction, Q2 catheter decline tied to recall-driven overstocking, narrower product and customer concentration, and execution demands from international expansion could keep the stock below prior valuation levels.
Catalyst clock
2026-08-06
Mixed Q2 print resets the near-term valuation debate
Lead driver: Sentiment · See AI snapshot
Momentum
6
9% active weight
Current posture
7d trendFlat
Δ7d
-0.5
Δ21d
-4.0
Value
56
28% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.1
Sentiment
78
62% active weight
Current posture
7d trendImproving
Δ7d
+9.4
Δ21d
+5.3
Why this grade
Composite grade B. Momentum 5.7 / Value 55.6 / Sentiment 77.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-06. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$88.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$65.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.89B
Beta
0.71
Shares Out
22.87M
P/E (TTM)
35.9
P/S (TTM)
7.71
P/FCF (TTM)
37.88
Rev YoY
+9.6%
EPS YoY
+15.5%
Gross Margin
+71.3%
Op Margin
+29.5%
Net Debt
-$173.53M
Current Ratio
15.89
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data